Document Detail


Sepsis, coagulation and anticoagulants.
MedLine Citation:
PMID:  20509839     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Sepsis is one of the major health problems all over the word. Its pathophysiological mechanisms are not completely understood, but coagulation alterations are a hallmark of this syndrome. There is a clear exacerbation of coagulation and a suppression of control mechanisms of this process, including a reduction in fibrinolysis with consequent impairment of fibrin removal. The leading cause of these alterations is the proinflammatory state of those patients, characterized by high cytokine levels, increase in adhesion molecules expression, endothelial and platelets activation, release of microparticles and other related phenomena. Moreover, coagulation and inflammation are linked in a variety of pathways with mutual activation that ultimately contributes for its maintenance. The components of this process will be herein discussed as well as therapeutical alternatives that have excessive coagulation as a target.
Authors:
Flavia Ribeiro Machado; Murillo Santucci Cesar
Related Documents :
11943929 - Hemoglobin binds melanoma cell tissue factor and enhances its procoagulant activity.
1995649 - Formation of meizothrombin as intermediate in factor xa-catalyzed prothrombin activatio...
1531589 - Activation of prothrombin in the presence of human umbilical-vein endothelial cells.
15819679 - Stored platelets contain residual amounts of tissue factor: evidence from studies on pl...
16131459 - Disseminated intravascular coagulation in an ambulatory young woman.
11263809 - Active tissue factor shed from human arterial smooth muscle cells adheres to artificial...
10897699 - Treatment of a patient with a deep leg ulcer using biatain adhesive.
1487689 - Neural cell adhesion molecule of taste buds.
21726849 - Patterns of corneal endothelialization and corneal clearance after descemet membrane en...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Endocrine, metabolic & immune disorders drug targets     Volume:  10     ISSN:  2212-3873     ISO Abbreviation:  Endocr Metab Immune Disord Drug Targets     Publication Date:  2010 Sep 
Date Detail:
Created Date:  2010-09-23     Completed Date:  2011-01-04     Revised Date:  2012-04-19    
Medline Journal Info:
Nlm Unique ID:  101269157     Medline TA:  Endocr Metab Immune Disord Drug Targets     Country:  United Arab Emirates    
Other Details:
Languages:  eng     Pagination:  204-13     Citation Subset:  IM    
Affiliation:
Department of Anesthesiology, Pain and Critical Care - Federal University of Sao Paulo, Sao Paulo, SP, Brazil.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Anticoagulants / blood*,  immunology
Blood Coagulation / immunology*
Blood Platelets / immunology*
Disseminated Intravascular Coagulation / blood*,  immunology,  therapy
Humans
Inflammation Mediators / blood
Sepsis / blood*,  complications,  immunology
Chemical
Reg. No./Substance:
0/Anticoagulants; 0/Inflammation Mediators

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pathomechanisms of myocardial dysfunction in sepsis.
Next Document:  Metabolic acidosis in sepsis.